PAVmed/$PAVM
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About PAVmed
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
- Ticker
- $PAVM
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 41
- Headquarters
- New York, United States
- Website
- www.pavmed.com
PAVmed Metrics
BasicAdvanced
$20M
-
-$9.85
0.52
-
Price and volume
Market cap
$20M
Beta
0.52
52-week high
$28.44
52-week low
$2.61
Average daily volume
27K
Financial strength
Current ratio
1.188
Quick ratio
1
Long term debt to equity
0.855
Total debt to equity
0.884
Interest coverage (TTM)
-1,405.42%
Profitability
EBITDA (TTM)
-26.624
Gross margin (TTM)
-220.54%
Net profit margin (TTM)
-10,794.64%
Operating margin (TTM)
-23,841.96%
Management effectiveness
Return on assets (TTM)
-39.69%
Return on equity (TTM)
-64.78%
Valuation
Price to revenue (TTM)
60.808
Price to book
0.58
Price to tangible book (TTM)
0.58
Price to free cash flow (TTM)
-0.875
Free cash flow yield (TTM)
-114.27%
Free cash flow per share (TTM)
-3.279
Growth
Revenue change (TTM)
-89.02%
Earnings per share change (TTM)
-139.40%
3-year revenue growth (CAGR)
-48.08%
3-year earnings per share growth (CAGR)
-70.18%
10-year earnings per share growth (CAGR)
-22.21%
PAVmed Financial Performance
Revenues and expenses
PAVmed Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.